Testing effectiveness (Phase 2)Looking for participantsNCT04305691What this trial is testingTrial of Ixazomib for Kaposi SarcomaWho this might be right forKaposi SarcomaSkin AIDS Malignancy Consortium 41
Not applicableStudy completedNCT01154543What this trial is testingSafety and Efficacy of Famciclovir in HIV1 Positive Adults With Recurrent Genital HerpesWho this might be right forHIV PositiveHerpes Simplex, Genital Holdsworth House Medical Practice 42
Testing effectiveness (Phase 2)Looking for participantsNCT04303117What this trial is testingPDS01ADC Monotherapy and in Combination With M7824 in Advanced Kaposi SarcomaWho this might be right forKaposi Sarcoma National Cancer Institute (NCI) 80
Not applicableUnknownNCT03371589What this trial is testingIntratympanic Stereoidal Injections for Facial Nerve PalsyWho this might be right forBell Palsy Hillel Yaffe Medical Center 30
Testing effectiveness (Phase 2)Study completedNCT00849147What this trial is testingBone Marrow Transplant From Partially Matched Donors and Nonmyeloablative Conditioning for Blood Cancers (BMT CTN 0603)Who this might be right forPrecursor B-Cell Lymphoblastic Leukemia-LymphomaLeukemia, Myeloid, AcuteBurkitt Lymphoma+3 more Medical College of Wisconsin 55
Not applicableStudy completedNCT00194155What this trial is testingCytomegalovirus (CMV) Infection in PregnancyWho this might be right forPregnancy ComplicationsCytomegalovirus Infection University of Pennsylvania 283
Large-scale testing (Phase 3)UnknownNCT04084626What this trial is testingPD1 Antibody and Lenalidomide as a Treatment for EBV-HLH or CAEBVWho this might be right forEBV Infection Beijing Friendship Hospital 40
Testing effectiveness (Phase 2)Study completedNCT00132015What this trial is testing17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Systemic MastocytosisWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+2 more National Institutes of Health Clinical Center (CC) 37
Not applicableStudy completedNCT00001560What this trial is testingClinical, Laboratory and Epidemiologic Pilot Studies of Individuals at High Risk for Viral-Associated CancersWho this might be right forAcquired Immunodeficiency SyndromeKaposi's SarcomaLeukemia+3 more National Cancer Institute (NCI) 24
Testing effectiveness (Phase 2)Study completedNCT02483182What this trial is testingSafety, Tolerability and Therapeutic Efficacy of Topical ZEP-3 Ointment (1.0%) for the Treatment of Cold SoresWho this might be right forHerpes Labialis Shulov Innovate for Science Ltd. 2012 210
Early research (Phase 1)Looking for participantsNCT06879340What this trial is testingEvaluating the Safety and Efficacy of DuoCAR20.19.22-D95 in Adult Patients With Relapsed or Refractory B-cell MalignanciesWho this might be right forB-Cell Non-Hodgkin LymphomaB-cell Acute Lymphoblastic Leukemia University of Kansas Medical Center 54
Early research (Phase 1)Study completedNCT02950220What this trial is testingPembrolizumab and Ibrutinib in Treating Patients With Relapsed or Refractory Non-Hodgkin LymphomaWho this might be right forB-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Classical Hodgkin LymphomaGrade 1 Follicular LymphomaGrade 2 Follicular Lymphoma+16 more Kami Maddocks 2
Not applicableLooking for participantsNCT07335874What this trial is testingOverview of Targeted Screening for Congenital Infection Guided by Neonatal Hearing ScreeningWho this might be right forNeonatal Hearing Loss University Hospital, Strasbourg, France 450
Not applicableLooking for participantsNCT06785818What this trial is testingLong-term Follow up Local Registry Study of Kymriah in South KoreaWho this might be right forB-Cell Acute Lymphoblastic Leukemia, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma Novartis Pharmaceuticals 500
Very early researchStudy completedNCT03825718What this trial is testingGC007F CAR-T Cell Immunotherapy for Relapsed or Refractory B- ALLWho this might be right forB-cell Acute Lymphoblastic Leukemia Hebei Yanda Ludaopei Hospital 29
Early research (Phase 1)Looking for participantsNCT04545762What this trial is testingAnti-CD19 Chimeric Antigen Receptor T Cells for Treatment of Relapsed or Refractory Non-Hodgkin LymphomaWho this might be right forRefractory Non-Hodgkin LymphomaBurkitt LymphomaMantle Cell Lymphoma+7 more C. Babis Andreadis 36
Early research (Phase 1)Ended earlyNCT00036855What this trial is testingRadiolabeled Monoclonal Antibody With or Without Peripheral Stem Cell Transplantation in Treating Children With Recurrent or Refractory LymphomaWho this might be right forAIDS-related Peripheral/Systemic LymphomaAIDS-related Primary CNS LymphomaPost-transplant Lymphoproliferative Disorder+4 more National Cancer Institute (NCI) 36
Not applicableNot Yet RecruitingNCT07721090What this trial is testingImproving Prescribing Quality for Oral Mucosal Disorders Using a Pharmacist-Led ModelWho this might be right forOral Lichen PlanusRecurrent Aphthous StomatitisBurning Mouth Syndrome+2 more University of Fujairah 336
Testing effectiveness (Phase 2)Ended earlyNCT01948180What this trial is testingCellular Immunotherapy Treatment Antigen-Directed for EBV LymphomaWho this might be right forLymphoma, Extranodal NK-T-CellEBV Cell Medica Ltd 15
Not applicableUnknownNCT01601925What this trial is testingDistances From Cricoid Cartilage to the Targets of Stellate Ganglion BlockWho this might be right forHerpes ZosterCRPS Yonsei University 42